Sven H. Schmidt

970 total citations
26 papers, 679 citations indexed

About

Sven H. Schmidt is a scholar working on Molecular Biology, Physiology and Nephrology. According to data from OpenAlex, Sven H. Schmidt has authored 26 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Physiology and 3 papers in Nephrology. Recurrent topics in Sven H. Schmidt's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Plant biochemistry and biosynthesis (3 papers) and Adenosine and Purinergic Signaling (3 papers). Sven H. Schmidt is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Plant biochemistry and biosynthesis (3 papers) and Adenosine and Purinergic Signaling (3 papers). Sven H. Schmidt collaborates with scholars based in Germany, United States and Switzerland. Sven H. Schmidt's co-authors include G. Obe, Rainer Jonas, Rainer Müller, Friedrich W. Herberg, Markus van der Giet, Jürgen Schmitt, Walter Zidek, Théo Gasser, Valentin Rousson and Annette Grüters and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

Sven H. Schmidt

26 papers receiving 668 citations

Peers

Sven H. Schmidt
Sven H. Schmidt
Citations per year, relative to Sven H. Schmidt Sven H. Schmidt (= 1×) peers Xingxing Zhu

Countries citing papers authored by Sven H. Schmidt

Since Specialization
Citations

This map shows the geographic impact of Sven H. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven H. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven H. Schmidt more than expected).

Fields of papers citing papers by Sven H. Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven H. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven H. Schmidt. The network helps show where Sven H. Schmidt may publish in the future.

Co-authorship network of co-authors of Sven H. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Sven H. Schmidt. A scholar is included among the top collaborators of Sven H. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven H. Schmidt. Sven H. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jucknischke, Ute, et al.. (2023). Antibody Profiling: Kinetics with Native Biomarkers for Diagnostic Assay and Drug Developments. Biosensors. 13(12). 1030–1030. 2 indexed citations
2.
Singh, Ranjan K., Giambattista Guaitoli, Felix von Zweydorf, et al.. (2022). Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2. Proceedings of the National Academy of Sciences. 119(9). 31 indexed citations
3.
Weng, Jui‐Hung, Phillip C. Aoto, Robin Lorenz, et al.. (2022). LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains. PLoS Biology. 20(2). e3001427–e3001427. 17 indexed citations
4.
Schmidt, Sven H., Jui‐Hung Weng, Phillip C. Aoto, et al.. (2021). Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2. Proceedings of the National Academy of Sciences. 118(23). 38 indexed citations
5.
Pautz, Sabine, et al.. (2020). Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2. Frontiers in Neuroscience. 14. 302–302. 33 indexed citations
6.
Taylor, Susan S., Jui‐Hung Weng, Phillip C. Aoto, et al.. (2020). Kinase Domain Is a Dynamic Hub for Driving LRRK2 Allostery. Frontiers in Molecular Neuroscience. 13. 538219–538219. 13 indexed citations
7.
Knape, Matthias J., Daniela Bertinetti, Jan Hornung, et al.. (2020). Molecular Basis for Ser/Thr Specificity in PKA Signaling. Cells. 9(6). 1548–1548. 2 indexed citations
8.
Becce, Fabio, et al.. (2020). Beta-hydroxy-beta-methylbutyrate (HMB) modifies amino acid metabolism in critically ill patients. a RCT. Clinical Nutrition ESPEN. 40. 428–428. 1 indexed citations
9.
Berger, Mette M., Olivier Pantet, N. Jacquelin-Ravel, et al.. (2018). Supplemental parenteral nutrition does not alter carbohydrate and protein metabolism and improves immunity: The SPN2 randomized trial. Clinical Nutrition. 37. S169–S169. 4 indexed citations
10.
Härtwig, Sven, Michael Tsokos, Sven H. Schmidt, & Roger W. Byard. (2010). Self-Constructed Shooting Devices Utilizing Manually-Impacted Firing-Pins (Suicide Machines). American Journal of Forensic Medicine & Pathology. 31(2). 192–194. 10 indexed citations
11.
Zebger‐Gong, Hong, Dominik N. Müller, Michaela Diercke, et al.. (2010). 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix. Journal of Hypertension. 29(2). 339–348. 36 indexed citations
12.
Schmidt, Sven H., Timm H. Westhoff, Ralf Ignatius, et al.. (2008). The uraemic toxin phenylacetic acid impairs macrophage function. Nephrology Dialysis Transplantation. 23(11). 3485–3493. 29 indexed citations
13.
Schmidt, Sven H., et al.. (2007). The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells. Nephrology Dialysis Transplantation. 23(1). 65–71. 37 indexed citations
14.
Meier, Friedegund, et al.. (2004). Kokzidioidomykose. Der Hautarzt. 55(12). 1143–1149. 5 indexed citations
15.
Shunmugaperumal, Tamilvanan, Sven H. Schmidt, Rainer Müller, & Simon Benita. (2004). In vitro adsorption of plasma proteins onto the surface (charges) modified-submicron emulsions for intravenous administration. European Journal of Pharmaceutics and Biopharmaceutics. 59(1). 1–7. 27 indexed citations
16.
Schmidt, Sven H.. (2003). Plasma protein adsorption patterns on surfaces of Amphotericin B-containing fat emulsions. International Journal of Pharmaceutics. 254(1). 3–5. 8 indexed citations
17.
Müller, Rainer, et al.. (2003). SolEmuls®—novel technology for the formulation of i.v. emulsions with poorly soluble drugs. International Journal of Pharmaceutics. 269(2). 293–302. 97 indexed citations
18.
Westhoff, Timm H., Joachim Jankowski, Sven H. Schmidt, et al.. (2003). Identification and Characterization of Adenosine 5′-Tetraphosphate in Human Myocardial Tissue. Journal of Biological Chemistry. 278(20). 17735–17740. 14 indexed citations
19.
l’Allemand, Dagmar, Sven H. Schmidt, Valentin Rousson, et al.. (2002). Associations between body mass, leptin, IGF-I and circulating adrenal androgens in children with obesity and premature adrenarche. European Journal of Endocrinology. 146(4). 537–543. 81 indexed citations
20.
Giet, Markus van der, Sven H. Schmidt, Markus Tölle, et al.. (2002). Effects of dinucleoside polyphosphates on regulation of coronary vascular tone. European Journal of Pharmacology. 448(2-3). 207–213. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026